Switzerland· 69954001

BCG-medac

A bcg-impfstoff product containing bacillus calmette-guérin (bcg) vivus attenuatum (rivm), registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L03AX03

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedBCG-medacATCL03AX03REGISTER NO.69954001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Bcg-impfstoff is registered in 11 of 19 countries.

Countries holding a registration under ATC L03AX03 (bcg-impfstoff), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Bcg-impfstoff · ATC L03AX03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
bacillus Calmette-Guérin (BCG) vivus attenuatum (RIVM)
Manufacturer
—
Country
Switzerland (CH)
ATC code
L03AX03
ATC class
BCG-Impfstoff
Defined daily dose
0.033 Darreichungsform, intravesikal
Swissmedic category
A
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680699540013
    1 Durchstf + 1 Instillationsbtl mit Lsg-mittel + Katheter + Gleitgel
    CHF 158.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b13515c9-be64-4a83-a301-4911eaf9ff30
GET /v1/drugs/b13515c9-be64-4a83-a301-4911eaf9ff30?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "bacillus calmette guerin (bcg, rivm)",
  "valid_from": "2026-09-01",
  "limitations": "[{\"description\":\"<!DOCTYPE html>\\n<html>\\n<head></head>\\n<body>\\n<p>BCG-medac wird verg&uuml;tet f&uuml;r die Behandlung nicht-invasiver urothelialer Harnblasenkarzinome:</p>\\n<ul>\\n<li>Kurative Behandlung eines Carcinoma in situ</li>\\n<li>Prophylaktische Behandlung zur Vermeidung eines erneuten Auftretens von:\\n<ul>\\n<li>Urothelialen Karzinomen beschr&auml;nkt auf die Schleimhaut\\n<ul style=\\\"list-style-type: square;\\\">\\n<li>Ta G1-G2 bei einem multifokalen Tumor und/oder Tumorrezidiv</li>\\n<li>Ta G3</li>\\n</ul>\\n</li>\\n<li>Urothelialen Karzinomen in der Lamina propria, aber nicht im Muskelgewebe der Blase (T1)</li>\\n<li>Carcinoma in situ</li>\\n</ul>\\n</li>\\n</ul>\\n</body>\\n</html>\",\"costApproval\":null,\"indication\":\"21999.01\",\"isNew\":true,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-09-01\",\"validTo\":null}]",
  "galenic_form": "Trockensub + Lsg-mittel, 2*10E8 – 3*10E9 CFU",
  "therapeutic_area": null,
  "sl_inclusion_date": "2026-09-01",
  "self_retention_pct": 10
}

See everything about bcg-impfstoff.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.